ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv vaccine cell molecular biology

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Black and gold sketch of Katalin Karikó and Drew Weissman.
Nobel Prize for mRNA Vaccines
Danielle Gerhard, PhD | Oct 2, 2023 | 5 min read
Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.
Systems Immunology: Understanding Responses to Vaccination and Infection
The Scientist | Mar 18, 2019 | 1 min read
The Scientist is bringing together a panel of experts to discuss their research and experiences in using systems immunology to gain new insights into immune responses to infection through single-cell data analysis, and into innate immune dysfunction in HIV infection.  
nk natural killer cell immunology immune cell adaptive innate immunity
Innate Immune Cells May Actually Remember Their Targets
Emma Yasinski | May 10, 2019 | 3 min read
Human natural killer cells, previously considered not to participate in adaptive immunity, remember viral antigens after initial exposures, according to a new study.
Vector did not kill HIV trial
Jef Akst | Jul 19, 2009 | 3 min read
New findings have disproved a leading explanation for why an experimental HIV vaccine made subjects more susceptible to the virus, reopening the door for further HIV vaccine efforts based on similar principles. Human Immunodeficiency VirusImage: NIAIDThe Merck-funded STEP study, which used an adenoviral vector to deliver an HIV vaccine candidate, was halted in 2007 after the data suggested the vaccine increased the risk of HIV infection. Researchers thought the effect might be due to an immune
Defeating the Virus
Wayne C. Koff | May 1, 2015 | 10+ min read
Recent discoveries are spurring a renaissance in HIV vaccine research and development.
Templates for a vaccine?
Quentin J. Sattentau and Andrew J. McMichael | Oct 1, 2010 | 4 min read
By Quentin J. Sattentau and Andrew J. McMichael Templates for a vaccine? New tools for HIV-1 antibody-based vaccine design Env is shown as a transparent mesh consisting of three gp120 molecules (red) noncovalently linked to three gp41 molecules (not modeled) on the surface of an HIV-1 virion. An area marking the CD4 binding surface is labeled yellow. Bill Schief, Dept of Biochemistry / University of Washington, Seattle The human immunodef
The Best Offense?
Simon Frantz | Sep 1, 2007 | 3 min read
The Best Offense? CCR5 inhibitors, moving toward market, suggest it may be a good defense By Simon Frantz Related Articles 5 HIV Treatment Strategies A piggyback attack: Using the common cold to deliver an HIV vaccine Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV Solving the viral spike: Can structural biology find a chink in HIV's armor? Reconstructing early HIV: The search for immunogen
Week in Review: July 13–17
Tracy Vence | Jul 17, 2015 | 3 min read
Removing mtDNA mutations; mini brains for studying autism; HIV vaccine selectivity; “speed cells” in rat brain; more
Math explains HIV immunity
Edyta Zielinska | May 4, 2010 | 2 min read
A mathematical model has revealed part of the secret to why some people linkurl:infected with HIV never get sick,;http://www.nature.com/nature/journal/vaop/ncurrent/full/nature08997.html providing a new target in the attempt to harness that ability in a vaccine, according to research published in __Nature.__ HIV particles (green) budding from a lymphocyte.Image: C. Goldsmith, CDC People who can control their HIV infections carry a specific subtype of the gene for the major histocompatability co

Run a Search

ADVERTISEMENT